Drug to Improve Fetal Growth May Impair Baby’s Postnatal Blood Pressure, Sugar Levels

Research suggests that a drug recently assessed as a potential treatment for fetal growth restriction may cause high blood pressure and raise blood sugar levels in offspring. The study urges practitioners to consider both short- and long-term effects when treating people with this pregnancy complication.